About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2013 (2013), Article ID 710421, 7 pages
http://dx.doi.org/10.1155/2013/710421
Research Article

Higher Prostate Weight Is Inversely Associated with Gleason Score Upgrading in Radical Prostatectomy Specimens

Departments of Urology and Pathology, Faculty of Medical Sciences, University of Campinas (Unicamp), Rua Tessália Vieira de Camargo 126, Cidade Universitária “Zeferino Vaz,” 13083-887 Campinas-SP, Brazil

Received 31 July 2013; Revised 23 September 2013; Accepted 23 September 2013

Academic Editor: Axel S. Merseburger

Copyright © 2013 Leonardo Oliveira Reis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Pinthus, M. Witkos, N. E. Fleshner et al., “Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome,” Journal of Urology, vol. 176, no. 3, pp. 979–984, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. R. King, J. E. McNeal, H. Gill, and J. C. Presti Jr., “Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients,” International Journal of Radiation Oncology Biology Physics, vol. 59, no. 2, pp. 386–391, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. F. K. Chun, T. Steuber, A. Erbersdobler et al., “Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology,” European Urology, vol. 49, no. 5, pp. 820–826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. L. Gonzalgo, P. J. Bastian, L. A. Mangold et al., “Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate,” Urology, vol. 67, no. 1, pp. 115–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Kvåle, B. Møller, R. Wahlqvist et al., “Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study,” BJU International, vol. 103, no. 12, pp. 1647–1654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Billis, L. A. Magna, and U. Ferreira, “Correlation between tumor extent in radical prostatectomies and preoperative PSA, histological grade, surgical margins, and extraprostatic extension: application of a new practical method for tumor extent evaluation,” International Braz J Urol, vol. 29, no. 2, pp. 113–120, 2003. View at Scopus
  7. J. I. Epstein, W. C. Allsbrook Jr., M. B. Amin et al., “The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma,” American Journal of Surgical Pathology, vol. 29, no. 9, pp. 1228–1242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Cookson, G. Aus, A. L. Burnett et al., “Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes,” Journal of Urology, vol. 177, no. 2, pp. 540–545, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Colleselli, A. E. Pelzer, E. Steiner et al., “Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSA range,” Prostate Cancer and Prostatic Diseases, vol. 13, no. 2, pp. 182–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Montironi, R. Mazzucchelli, M. Scarpelli et al., “Prostate carcinoma II: prognostic factors in prostate needle biopsies,” BJU International, vol. 97, no. 3, pp. 492–497, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. N. J. Fitzsimons, J. C. Presti Jr., C. J. Kane et al., “Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?” Journal of Urology, vol. 176, no. 6, part 1, pp. 2453–2458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Müntener, J. I. Epstein, D. J. Hernandez et al., “Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy,” European Urology, vol. 53, no. 4, pp. 767–776, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. F. B. Serkin, D. W. Soderdahl, J. Cullen, Y. Chen, and J. Hernandez, “Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7,” Urologic Oncology, vol. 28, no. 3, pp. 302–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Freedland, C. J. Kane, C. L. Amling, W. J. Aronson, M. K. Terris, and J. C. Presti Jr., “Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications,” Urology, vol. 69, no. 3, pp. 495–499, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. D. Sved, P. Gomez, M. Manoharan, S. S. Kim, and M. S. Soloway, “Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer,” Journal of Urology, vol. 172, no. 1, pp. 98–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Ozden, C. V. Oztekin, O. Ugurlu, S. Gokkaya, M. Yaris, and A. Memis, “Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy,” Urologia Internationalis, vol. 83, no. 2, pp. 146–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. K. Hong, B. K. Han, S. T. Lee et al., “Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi (≥12)-core prostate biopsy,” World Journal of Urology, vol. 27, no. 2, pp. 271–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Dong, J. S. Jones, A. J. Stephenson, C. Magi-Galluzzi, A. M. Reuther, and E. A. Klein, “Prostate cancer volume at biopsy predicts clinically significant upgrading,” Journal of Urology, vol. 179, no. 3, pp. 896–900, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Liu, J. D. Brooks, M. Ferrari, R. Nolley, and J. C. Presti Jr., “Small prostate size and high grade disease-biology or artifact?” Journal of Urology, vol. 185, no. 6, pp. 2108–2111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. T. C. Ngo, S. L. Conti, R. Shinghal, and J. C. Presti Jr., “Prostate size does not predict high grade cancer,” Journal of Urology, vol. 187, no. 2, pp. 477–480, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Rahmouni, A. Yang, C. M. Tempany et al., “Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography,” Journal of Computer Assisted Tomography, vol. 16, no. 6, pp. 935–940, 1992. View at Scopus
  22. M. Varma and J. M. Morgan, “The weight of the prostate gland is an excellent surrogate for gland volume,” Histopathology, vol. 57, no. 1, pp. 55–58, 2010. View at Publisher · View at Google Scholar · View at Scopus